Imagecube: an astronomical Python package for organizing and processing multi-wavelength astronomical data

<p>Astropy is a community Python library for astronomy. We have developed Imagecube as an Astropy affiliated package for processing multiwavelength (spectro)-imaging. This module automates tedious steps of image processing and analysis and delivers a science-ready image datacube. The included steps involve converting to common flux units, image registration to a common WCS, and convolution to a common resolution. Individual steps can be performed separately. We will show examples of Imagecube in action and provide an update on its current status.</p

LianouHelAS2013.pdf

<div>Astropy is a community python library for astronomy. Imagecube has been developed as an Astropy affiliated package for processing multiwavelength (spectro)-imaging. This module automates tedious steps of image processing and analysis and delivers a science-ready image datacube. The included steps involve converting to common flux units, image registration to a common WCS, and convolution to a</div><div>common resolution. Individual steps can be performed separately. We test the module using the dwarf galaxy NGC1569 by producing its observed spectral energy distribution (SED) on a pixel-by-pixel basis.</div

MOESM1 of Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

Additional file 1. List of prescribed drug for each minor ailment with their prices and markup. This table contains list of all prescribed drug for 14 minor ailment along with their price and mark-up fee in PPMA

Characteristics of HIV negative and positive groups.

<p>Characteristics of HIV negative and positive groups.</p

Willingness to shorten lifespan for end of life research.

<p>Our surveys found that 69.2% (<i>n</i> = 68) of HIV-positive and 70.8% (<i>n</i> = 261) of HIV-negative participants were willing to shorten their lifespans for the sake of end of life research. A higher proportion (31.2%) of the HIV-positive group was willing to donate >4 weeks of their lives. About a third of respondents in both groups stated that they were unwilling to shorten their lifespans for the sake of research.</p

Attitudes toward research participation by HIV status.

<p>Attitudes toward research participation by HIV status.</p

Willingness to be exposed to infectious pathogens for end of life research.

<p>Our surveys found that around one-third of the HIV-negative group was willing to be exposed to and infected by an infectious pathogen for the sake of research. Participants were most willing to be exposed to streptococcus (33.6%. <i>n</i> = 118) infections, followed by HIV (29.9%, <i>n</i> = 105).</p

Questions from IRB-Approved Key Informant Interview Guides.

<p>Questions from IRB-Approved Key Informant Interview Guides.</p

Perceived Unacceptable Risks in HIV Cure Research from Key Informants (People Living with HIV, Clinician-Researchers and Policy-Makers/Bioethicists, n = 36), United States (2015–2016).

<p>Perceived Unacceptable Risks in HIV Cure Research from Key Informants (People Living with HIV, Clinician-Researchers and Policy-Makers/Bioethicists, n = 36), United States (2015–2016).</p

Perceived Risks of HIV Cure Research from People Living with HIV (PLWHIV), n = 12, United States (2015–2016).

<p>Perceived Risks of HIV Cure Research from People Living with HIV (PLWHIV), n = 12, United States (2015–2016).</p